Cargando…

Recent developments in the diagnosis and management of tuberculosis

Tuberculosis (TB) is a major public health issue worldwide, with ~9.6 million new incident cases and 1.5 million deaths in 2014. The End-TB Strategy launched by the World Health Organization in the context of the post-2015 agenda aims to markedly abate the scourge of TB towards global elimination, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulis, Giorgia, Centis, Rosella, Sotgiu, Giovanni, D’Ambrosio, Lia, Pontali, Emanuele, Spanevello, Antonio, Matteelli, Alberto, Zumla, Alimuddin, Migliori, Giovanni Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093435/ https://www.ncbi.nlm.nih.gov/pubmed/27808163 http://dx.doi.org/10.1038/npjpcrm.2016.78

Ejemplares similares

New anti-tuberculosis drugs and regimens: 2015 update
por: D'Ambrosio, Lia, et al.
Publicado: (2015)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021)

Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

Tuberculosis in the time of COVID-19: quality of life and digital innovation
por: Visca, Dina, et al.
Publicado: (2020)

A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European Respiratory Society-World Health Organization tuberculosis Consilium
por: D’Ambrosio, Lia, et al.
Publicado: (2017)

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis
por: Migliori, Giovanni Battista, et al.
Publicado: (2019)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
por: Maryandyshev, Andrey, et al.
Publicado: (2017)

Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs
por: Pontali, Emanuele, et al.
Publicado: (2022)

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?
por: Muñoz-Torrico, Marcela, et al.
Publicado: (2016)

COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
por: García-García, José-María, et al.
Publicado: (2022)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

The battle against colistin-resistant E. coli and the need for a one health approach
por: Danaei, Bardia, et al.
Publicado: (2023)

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
por: Nasiri, Mohammad Javad, et al.
Publicado: (2022)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones
por: Migliori, Giovanni Battista, et al.
Publicado: (2012)

Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia
por: Zampogna, Elisabetta, et al.
Publicado: (2021)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Tuberculosis series
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey
por: Amicosante, Massimo, et al.
Publicado: (2017)

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study
por: Nalunjogi, Joanitah, et al.
Publicado: (2023)

The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
por: Arbex, Marcos Abdo, et al.
Publicado: (2015)

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

Tuberculosis: Epidemiology and Control
por: Sulis, Giorgia, et al.
Publicado: (2014)

The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2023)

Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network
por: D’Ambrosio, Lia, et al.
Publicado: (2021)

Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
por: Tiberi, Simon, et al.
Publicado: (2021)

The Role of Blood Gas Analysis in the Post-Acute Phase of COVID-19 Pneumonia
por: Visca, Dina, et al.
Publicado: (2022)

Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts
por: Motta, I., et al.
Publicado: (2020)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
por: Tadolini, Marina, et al.
Publicado: (2016)

Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)
por: Ong, Catherine Wei Min, et al.
Publicado: (2020)

Eliminating tuberculosis in Latin America: making it the point
por: Duarte, Raquel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d20mt0c7urh73dvkpihhd9m6k1